Padmanabh P. Bhatt - Feb 22, 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Sr. VP of IP, CSO
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Stock symbol
SUPN
Transactions as of
Feb 22, 2023
Transactions value $
$0
Form type
4
Date filed
2/24/2023, 04:06 PM
Previous filing
Jan 19, 2023
Next filing
Feb 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Award $0 +750 +30.04% $0.00 3.25K Feb 22, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Restricted Stock Units Disposed to Issuer $0 -750 -25% $0.00 2.25K Feb 22, 2023 Common Stock 750 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 853 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
F2 Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F3 These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023.